Retina/Vitreous News

SEVILLE, Spain — In this Healio Video Perspective from the Congress on Controversies in Ophthalmology, Patricia Udaondo, MD, PhD, highlights the meeting’s debate sessions on new anti-VEGF therapies.

SEVILLE, Spain — In this Healio Video Perspective, M. Francesca Cordeiro, MD, PhD, summarizes three more hot topics in glaucoma discussed at the Congress on Controversies in Ophthalmology.

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.

In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion.

  The FDA issued a complete response letter for a supplemental biologics license application, in which it did not approve extending the dosing intervals for Eylea HD, according to a press release from Regeneron.

The FDA granted regenerative medicine advanced therapy designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

SEVILLE, Spain — Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.

SEVILLE, Spain — Home monitoring of neovascular age-related macular degeneration, an interesting concept with many potential benefits, has entered the retina space in the U.S. with the Scanly Home OCT monitoring program from Notal Vision.

This story has a lot of personal sentiment and comes from the last words spoken by my brother at the end of 2018, the day he decided to tell his best friend — me — that he was dying of cancer.